In the second episode of The Lung Lab, Dr. Lisa Lancaster – director of the Interstitial Lung Disease (ILD) program at Vanderbilt University and chief medical officer at Endeavor Biometrics – discusses the long and winding road many lung disease patients often face on their way to diagnosis.

A pulmonologist with over 25 years of experience and 85 clinical trials behind her, Dr. Lancaster is one of the most respected voices in the ILD space. She shares her perspective on the emotional challenges of delivering life-changing news, the promise of emerging therapies, and the future of ILD treatment she hopes to see.

We are thrilled to announce the launch of The Lung Lab, our new podcast exploring how OSIC is redefining rare and progressive lung disease— from how it is detected, to how it is measured, to how it is ultimately treated.

Hosted by our Executive Director Elizabeth Estes, each episode looks at how rare and progressive lung diseases are being understood today and where things may be heading next, from earlier detection to new approaches in treatment. The series brings together clinicians, scientists and technologists working at the intersection of imaging, data and disease.

In our first episode, “What If We Could? The Story Behind The World’s Largest Lung Disease Database,” Elizabeth discusses how OSIC began and shares a preview of the upcoming season.

New episodes will be released every other week over the next three months, and will explore the real challenges holding lung disease research back – including inconsistent measurement and fragmented data – and highlight the breakthroughs and the people emerging to solve them.

The goal of this new podcast is simple: to bring together the people and ideas shaping what comes next, and to make the conversation more accessible.

And the work is grounded in something bigger: the need to make real, and, hopefully, radical progress on behalf of patients, caregivers and families who are living with these diseases every day.